Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Proteomics|October 22, 2008
Riboproteomic analysis of polypeptides interacting with the internal ribosome-entry site element of foot-and-mouth disease viral RNAAlmudena Pacheco, Sandrine Reigadas, Encarnación Martínez-Salas
Plos One|May 23, 2012
K65R in subtype C HIV-1 isolates from patients failing on a first-line regimen including d4T or AZT: comparison of Sanger and UDP sequencing dataPatricia Recordon-Pinson, Jennifer Papuchon, Sandrine Reigadas, et al.
AIDS Research and Human Retroviruses|July 1, 2009
Pol bootscanning analysis of HIV type 1 can exhibit unexpected recombinationsAnne-Cécile Jeannot, Sandrine Reigadas, Marie-Helene Schrive, et al.
FEBS Letters|December 7, 2005
Specific interference between two unrelated internal ribosome entry site elements impairs translation efficiencySandrine Reigadas, Almudena Pacheco, Jorge Ramajo, et al.
International Journal of Antimicrobial Agents|June 18, 2014
In vitro analysis of the susceptibility of HIV-1 subtype A and CRF01_AE integrases to raltegravirPantxika Bellecave, Laurent Malato, Christina Calmels, et al.
Biochemistry|September 28, 2006
Aptamers targeted to an RNA hairpin show improved specificity compared to that of complementary oligonucleotidesFabien Darfeuille, Sandrine Reigadas, Jens Bo Hansen, et al.
RNA Biology|February 15, 2007
Endogenous expression of an anti-TAR aptamer reduces HIV-1 replicationGaëlle Kolb, Sandrine Reigadas, Daniela Castanotto, et al.
FEBS Letters|February 6, 2007
Systematic screening of LNA/2'-O-methyl chimeric derivatives of a TAR RNA aptamerCarmelo Di Primo, Ivo Rudloff, Sandrine Reigadas, et al.
AIDS Research and Human Retroviruses|July 31, 2013
Detection of low-frequency HIV type 1 reverse transcriptase drug resistance mutations by ultradeep sequencing in naive HIV type 1-infected individualsPantxika Bellecave, Patricia Recordon-Pinson, Jennifer Papuchon, et al.
Antiviral Therapy|March 5, 2015
Risk of virological failure in HIV-1-infected patients experiencing low-level viraemia under active antiretroviral therapy (ANRS C03 cohort study)Marie-Anne Vandenhende, Adélaïde Perrier, Fabrice Bonnet, et al.
Pageof 4